等待开盘 06-26 09:30:00 美东时间
-1.160
-2.72%
Harrow relaunches Verkazia for VKC treatment, targeting pediatric eye disease with a steroid-sparing therapy option.
06-11 23:42
The market remains obsessed with headlines, politics, tariffs, inflation scares...
05-29 00:18
Companies Reporting Before The Bell • United Parks & Resorts (NYSE:PRKS) is...
05-11 19:11
LogiCare3PL today announced it has been selected by Harrow, Inc. (NASDAQ:HROW) as a distribution partner for Harrow's portfolio of ophthalmic disease management solutions. Effective February 1, 2026, LogiCare3PL is
04-14 22:35
Harrow stock drops after earnings miss and weak 2026 outlook, despite revenue growth and new product plans.
03-03 21:11
Companies Reporting Before The Bell • Zymeworks (NASDAQ:ZYME) is expected to re...
03-02 19:11
Companies Reporting Before The Bell • CBAK Energy Tech (NASDAQ:CBAT) is likely ...
2025-11-10 19:12
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Harrow (NASDAQ:HROW) in the last three months. The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and d...
2024-08-29 23:00